Sanofi and Mannkind launch inhaled insulin in the United StatesSanofi and Mannkind Corporation have launched Afrezza, an inhaled insulin approved to control high blood sugar in adults with type 1 and type 2 diabetes.…
Structure of translocator protein hints at role in disease Two research groups have independently solved the structures of similar translocator proteins, offering clues about its function that could spur the development of targeted drugs.…
UK government provides £13.7m for ‘stratified medicine’ collaborationsThe UK government has announced £13.7m of funding for four ‘stratified medicine’ collaborations with the Medical Research Council.…
Cholic acid named ‘Golden Pill’ in Prescrire’s annual awards‘A drug used to treat children with a rare genetic condition who are unable to produce bile and risk fatal liver failure has received international recognition.…
First-in-class oral drug approved for psoriasis conditions in Europe The European Commission has authorised apremilast (Celgene’s Otezla), a first-in-class oral drug for the treatment of chronic plaque psoriasis and psoriatic arthritis in patients who have failed first-line systemic therapies.…
Perception of drug cost influences placebo response in Parkinson’s disease Treatment perceived to be expensive, even though it was a placebo, led to a two-fold improvement in motor function in Parkinson’s disease patients compared with a treatment perceived to be cheap.…
Study questions FDA warning over adverse cognitive effects of statins In 25 placebo-controlled trials involving nearly 47,000 patients, adverse cognitive outcomes attributable to statins were rarely reported, researchers found.…
Eculizumab — with £340,200 price tag — gets go ahead from NICEEculizumab, dubbed “the world’s most expensive drug”, is being made available on the NHS in England following guidance from the National Institute for Health and Care Excellence.…
Drug manufacturers propose alert system to mitigate medicine shortages European drug manufacturers have developed a communications framework which they claim could help prevent medicines shortages or lessen their impact.…
Older patients taking anticholinergic drugs are at risk of dementia People aged over 65 years who take some common over-the-counter or prescribed medicines for allergy, depression or an overactive bladder have an increased risk of developing dementia.…